Concepedia

Maureen Dillon

MD

Statistics

Publications

13

Citations

3.2K

H-Index

12

Active since

1999

Affiliations

Eloxx Pharmaceuticals (United States)(Current)

Kidney Associates

University of California, San Francisco

University of California San Francisco Medical Center

Washington University in St. Louis

Maureen Dillon is an author at Eloxx Pharmaceuticals (United States) specializing in medicine, dialysis, and nephrology.

Publications per year

1999–2014

13

Publications

13

Cardiac calcification in adult hemodialysis patients

Paolo Raggi, Amy Boulay, Scott Chasan-Taber et al. · Journal of the American College of Cardiology · 2002 · 1.1K citations

Medicine, Cardiology, Nephrology +14

Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients

Wadi N. Suki, Raja I. Zabaneh, José L. Cangiano et al. · Kidney International · 2007 · 523 citations · Full text

Medicine, Nephrology, Pharmacology +14

Colesevelam Hydrochloride (Cholestagel)

Michael H. Davidson, Maureen Dillon, Bruce R. Gordon et al. · Archives of Internal Medicine · 1999 · 308 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

RenaGel®, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone

Eduardo A. Slatopolsky, Steven K. Burke, Maureen Dillon · Kidney International · 1999 · 304 citations

Medicine, Nephrology, Nutrition +14

Long-term effects of sevelamer hydrochloride on the calcium × phosphate product and lipid profile of haemodialysis patients*

Glenn M. Chertow, Steven K. Burke, Maureen Dillon et al. · Nephrology Dialysis Transplantation · 1999 · 300 citations

Medicine, Nephrology, Pharmacotherapy +15

1–5 of 13